RF32 | PSUN58 BIO89-100 Treatment Ameliorates a Subclinical Increase in Spleen Volume in Non-cirrhotic NASH in Correlation With Change in Liver Fat, HOMA-IR and Inflammatory Markers in a Phase 1b/2a, Placebo-Controlled, Double-Blind Proof of Concept Study

BACKGROUND AND AIMS: Portal venous pressure may begin to rise due to steatosis-induced changes in sinusoidal homeostasis in early stages of NASH and may contribute to progression of fibrosis and portal hypertension1. FGF21 is an endogenous hormone regulating carbohydrate, lipid and energy metabolism...

Descripción completa

Detalles Bibliográficos
Autores principales: Frias, Juan, Johansson, Lars, Will Charlton, R, Feng, Shibao, Agollah, Germaine D, Mansbach, Hank, Margalit, Maya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624706/
http://dx.doi.org/10.1210/jendso/bvac150.535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624706/
http://dx.doi.org/10.1210/jendso/bvac150.535

Ejemplares similares